Skip to main content
NUTRITION 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Food Systems

Global and Public Health Nutrition

Session: Opportunities and Challenges of Shifting to Plant-based Proteins for Sustainable Diets (Sponsored Satellite Program)

Panel Discussion - Opportunities and Challenges of Shifting to Plant-based Proteins for Sustainable Diets (Sponsored Satellite Program)

Sunday, July 23, 2023
7:35 PM – 8:00 PM ET
Location:  Republic Ballroom

Sponsored by Nestle R&D

    Chair(s)

  • Petra Klassen Wigger, PhD (she/her/hers)

    Global Scientific Advisor Nutrition and Health
    Nestlé Research and Development
    Lausanne, Vaud, Switzerland

    Disclosure(s): Nestlé Research and Development: Employee (Ongoing)

    • Co-Chair(s)

  • MC

    Melina Claussnitzer, PhD

    Assistant Professor
    Harvard University

    Disclosure information not submitted.

    • Speaker(s)

  • Isabelle Privat, PhD (she/her/hers)

    Plant & Nutrition Department Head
    Nestlé Research and Development
    Tours, Centre, France

    Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.

  • Remko Boom, PhD (he/him/his)

    Professor
    Wageningen University and Research
    Ede, Gelderland, Netherlands

    Disclosure(s): dsm-firmenich: Advisory Committee/Board Member (Ongoing)

  • Christopher D. Gardner, PhD

    Rehnborg Farquhar Professor of Medicine
    Stanford Prevention Research Center
    Stanford University School of Medicine
    Stanford, CA, USA

    Disclosure information not submitted.

  • Martin W. Bloem, MD, PhD

    Professor
    Johns Hopkins Bloomberg School of Public Health
    Baltimore, Maryland, United States

    Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.

Disclosure(s):
Petra Klassen Wigger, PhD: Nestlé Research and Development: Employee (Ongoing)
Isabelle Privat, PhD: No relevant financial relationship(s) with ineligible companies to disclose.
Remko Boom, PhD: dsm-firmenich: Advisory Committee/Board Member (Ongoing)
Martin W. Bloem, MD, PhD: No relevant financial relationship(s) with ineligible companies to disclose.